Kimura Rie, Matsuki Norio
Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo 113-0033, Japan.
J Physiol. 2008 Jul 1;586(13):3195-206. doi: 10.1113/jphysiol.2008.151894. Epub 2008 May 15.
Synaptic plasticity is the foundation of learning and memory. The protein kinase CK2 phosphorylates many proteins related to synaptic plasticity, but whether it is directly involved in it has not been clarified. Here, we examined the role of CK2 in synaptic plasticity in hippocampal slices using the CK2 selective inhibitors 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and 4,5,6,7-tetrabromobenzotriazole (TBB). These significantly inhibited N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP). DRB also inhibited NMDA receptor-mediated synaptic transmission, while leaving NMDA receptor-independent LTP unaffected. NMDA receptors thus appear to be the primary targets of CK2. Although both long-term depression (LTD) and LTP are induced by the influx of Ca(2+) through NMDA receptors, surprisingly, LTD was not affected by CK2 inhibitors. We postulated that the LTP-selective modulation by CK2 is due to selective modulation of NMDA receptors, and tested two hypotheses concerning the modulation of NMDA receptors: (i) CK2 selectively modulates NR2A subunits possibly related to LTP, but not NR2B subunits possibly related to LTD; and (ii) CK2 selectively affects synaptic but not extrasynaptic NMDA receptors whose activation is sufficient to induce LTD. DRB decreased NMDA receptor-mediated synaptic transmission in the presence of selective NR2A subunit antagonist. The former hypothesis thus appears unlikely to be correct. However, DRB decreased synaptic NMDA receptor responses in cultured hippocampal neurons without affecting extrasynaptic NMDA receptor current. These findings support the latter hypothesis, that CK2 selectively affects LTP by selective modification of synaptic NMDA receptors in a receptor-location-specific manner.
突触可塑性是学习和记忆的基础。蛋白激酶CK2可使许多与突触可塑性相关的蛋白质磷酸化,但其是否直接参与其中尚不清楚。在此,我们使用CK2选择性抑制剂5,6-二氯-1-β-D-呋喃核糖基苯并咪唑(DRB)和4,5,6,7-四溴苯并三唑(TBB)研究了CK2在海马切片突触可塑性中的作用。这些抑制剂显著抑制了N-甲基-D-天冬氨酸(NMDA)受体依赖性长时程增强(LTP)。DRB还抑制了NMDA受体介导的突触传递,而不影响非NMDA受体依赖性LTP。因此,NMDA受体似乎是CK2的主要作用靶点。尽管长时程抑制(LTD)和LTP均由Ca(2+)通过NMDA受体流入所诱导,但令人惊讶的是,LTD不受CK2抑制剂的影响。我们推测CK2对LTP的选择性调节是由于对NMDA受体的选择性调节,并测试了两个关于NMDA受体调节的假设:(i)CK2选择性调节可能与LTP相关的NR2A亚基,而不调节可能与LTD相关的NR2B亚基;(ii)CK2选择性影响突触而非突触外NMDA受体,其激活足以诱导LTD。在存在选择性NR2A亚基拮抗剂的情况下,DRB降低了NMDA受体介导的突触传递。因此,前一个假设似乎不太可能正确。然而,DRB降低了培养的海马神经元中突触NMDA受体的反应,而不影响突触外NMDA受体电流。这些发现支持了后一个假设,即CK2通过以受体定位特异性方式选择性修饰突触NMDA受体来选择性影响LTP。